News
Surveillance and medical protocols are in place, but environmental factors for the epidemic reappearing regularly cannot be ruled out.
How fast does a fish disappear? How long does it take to erase all evidence of its life, to turn it into a fillet? What about ...
Three De-suup trainees, a man and two women, have died at the national referral hospital after a Leptospirosis outbreak at a ...
The report provides a detailed analysis of the current acute respiratory distress syndrome (ARDS) marketed drugs and late-stage pipeline drugs. Inside the ARDS Market | How Tech, Awareness, Rising ...
The R/I ratio showed limited accuracy in predicting lung recruitability in ARDS but reliably identified low recruiters.
In the U.S. alone, ARDS affects over 500,000 patients per year, or roughly 10% of all ICU admissions. With no effective pharmacological therapies currently available for ARDS and its high ...
Emerging Acute Respiratory Distress Syndrome therapies in the different phases of clinical trials are- RSBT-001, AVM0703, CYP 001, AV 001, ALT-100, STSA-1002, GEn-1124, Descartes 30, Rhu-pGSN ...
Even with aggressive medical management, 40% of ARDS patients do not survive, and those who do may suffer from long-term complications, including impaired lung function and reduced quality of life.
Patients with acute respiratory distress syndrome faced an accelerated and heightened risk for 90-day mortality between ages 11 and 65, according to results published in American Journal of ...
Dublin, Dec. 06, 2024 (GLOBE NEWSWIRE) -- The "Acute Respiratory Distress Syndrome Market Insight, Epidemiology and Market Forecast - 2034" report has been added to ResearchAndMarkets.com's ...
Acute chest syndrome is a serious and life threatening complication of sickle cell anemia. Early recognition of symptoms, prompt diagnosis, and effective treatment are important in managing this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results